Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Haleon plc
Beauty and consumer health care weren’t among the the consumer packaged goods categories showing private label market-share growth during April-June period. Consumer health industry executives see more spending on private label in some categories but without affecting their results.
Futura Medical's MED3000 erectile dysfunction gel gets OTC approval in the Kingdom of Saudi Arabia, where Switzerland's Labatec Pharma has the rights to commercialize the product under the Eroxon brand.
Haleon steps into the US OTC erectile dysfunction market with a commercialization deal for Futura's drug-free MED3000 gel, recently approved by the FDA as a de novo medical device.
European consumer health companies have the luxury of voluntarily setting sustainability goals. But with regulations looming and pressure from retailers and consumers mounting, compliance with mandatory standards is on the horizon, says Haleon’s sustainability chief Joe Muscat.
- OTC, Consumer
- Other Names / Subsidiaries
- GSK/Pfizer JV
- Hindustan Milkfood Manufacturers Pvt Ltd
- HMM Ltd.
- SmithKline Beecham Brands Ltd.
- SmithKline Beecham Consumer Healthcare Ltd.
- GlaxoSmithKline Consumer Healthcare Limited
- GSK Consumer Healthcare
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.